Development of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; p. vi330
Main Authors Prawira, A., Dufort, P., Halankar, J., Paravasthu, D.M., Hansen, A., Spreafico, A., Razak, A.R. Abdul, Chen, E., Jang, R.W., Metser, U., Siu, L.L.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2016
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw376.08